Skip to main content

Walbert Timothy P's Form 4 filing

Horizon Therapeutics Public Ltd Co (HZNP) · filed Dec 1, 2021

Accession no.
0001209191-21-067322
Filed
Dec 1, 2021
Trade date
Nov 30, 2021
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $5.12M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Walbert Timothy PCIK 0001349376Director, Officer (Chairman, President and CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 30, 2021Ordinary SharesSSaleDisposed−20,638$101.48−$2,094,344.24533,844Direct
Nov 30, 2021Ordinary SharesSSaleDisposed−15,875$102.62−$1,629,092.5517,969Direct
Nov 30, 2021Ordinary SharesSSaleDisposed−13,487$103.54−$1,396,443.98504,482Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)